×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OSUR – orasure technologies, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OSUR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/15
01:00 pm
osur
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
Low
Report
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
1/15
10:41 am
osur
Altai Capital nominates two directors to OraSure's board [Seeking Alpha]
Low
Report
Altai Capital nominates two directors to OraSure's board [Seeking Alpha]
1/15
08:30 am
osur
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
Medium
Report
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
1/7
06:42 am
osur
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device [Yahoo! Finance]
Low
Report
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device [Yahoo! Finance]
1/5
08:06 am
osur
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review [Yahoo! Finance]
Low
Report
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review [Yahoo! Finance]
1/5
08:00 am
osur
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review
Medium
Report
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review
12/17
02:28 pm
osur
OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates [Yahoo! Finance]
Low
Report
OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates [Yahoo! Finance]
12/17
01:23 pm
osur
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
Low
Report
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2025
04:05 pm
osur
orasure technologies, inc.
BEAT
Report
-6.6%
orasure technologies, inc.
8/5/2025
04:05 pm
osur
orasure technologies, inc.
IN-LINE
Report
-8.5%
orasure technologies, inc.
5/7/2025
04:05 pm
osur
orasure technologies, inc.
BEAT
Report
-5.5%
orasure technologies, inc.
2/25/2025
04:05 pm
osur
orasure technologies, inc.
IN-LINE
Report
-23.5%
orasure technologies, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/15
02:45 pm
osur
Form DEFA14A ORASURE TECHNOLOGIES
Low
Report
Form DEFA14A ORASURE TECHNOLOGIES
1/15
08:46 am
osur
Form DFAN14A ORASURE TECHNOLOGIES Filed by: Altai Capital Management, L.P.
Medium
Report
Form DFAN14A ORASURE TECHNOLOGIES Filed by: Altai Capital Management, L.P.
1/15
08:45 am
osur
Form SCHEDULE 13D/A ORASURE TECHNOLOGIES Filed by: Altai Capital Management, L.P.
Medium
Report
Form SCHEDULE 13D/A ORASURE TECHNOLOGIES Filed by: Altai Capital Management, L.P.
1/5
08:05 am
osur
Form 8-K ORASURE TECHNOLOGIES For: Jan 05
Medium
Report
Form 8-K ORASURE TECHNOLOGIES For: Jan 05
12/19
04:09 pm
osur
Form 4 ORASURE TECHNOLOGIES For: Dec 17 Filed by: Kenny John P.
Low
Report
Form 4 ORASURE TECHNOLOGIES For: Dec 17 Filed by: Kenny John P.
12/17
04:10 pm
osur
Form DEFA14A ORASURE TECHNOLOGIES
Low
Report
Form DEFA14A ORASURE TECHNOLOGIES
12/17
08:06 am
osur
Form SCHEDULE 13D/A ORASURE TECHNOLOGIES Filed by: Altai Capital Management, L.P.
Neutral
Report
Form SCHEDULE 13D/A ORASURE TECHNOLOGIES Filed by: Altai Capital Management, L.P.
12/4
01:46 pm
osur
Form 144 ORASURE TECHNOLOGIES Filed by: Aspinall Mara G.
Low
Report
Form 144 ORASURE TECHNOLOGIES Filed by: Aspinall Mara G.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/27
OraSure Technologies, Inc. (NASDAQ: OSUR) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.
21.5%
3/24 OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 17.1%
4/9 Form 4 ORASURE TECHNOLOGIES For: Apr 08 Filed by: Datin James A 9.0%
4/6 OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test 7.8%
8/6 OraSure Announces 2019 Second Quarter Financial Results 7.6%
6/26 OraSure Technologies and Others Join Forces for HIV Testing Day 7.2%
4/28 What is antigen testing? How a new test could help track the coronavirus outbreak [MSNBC.com] 4.3%
4/8 OraSure Technologies Appoints David J. Shulkin, M.D. to Board of Directors 4.0%
5/10 Form SC 13G/A ORASURE TECHNOLOGIES Filed by: ALGER ASSOCIATES INC 3.6%
12/17 Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test 3.6%
3/24 OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 17.1%
4/9 Form 4 ORASURE TECHNOLOGIES For: Apr 08 Filed by: Datin James A 9.0%
4/6 OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test 7.8%
8/6 OraSure Announces 2019 Second Quarter Financial Results 7.6%
6/26 OraSure Technologies and Others Join Forces for HIV Testing Day 7.2%
4/28 What is antigen testing? How a new test could help track the coronavirus outbreak [MSNBC.com] 4.3%
4/8 OraSure Technologies Appoints David J. Shulkin, M.D. to Board of Directors 4.0%
5/10 Form SC 13G/A ORASURE TECHNOLOGIES Filed by: ALGER ASSOCIATES INC 3.6%
12/17 Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test 3.6%
TOP News Decliners
2/19
Q4/2019 12/31/2019 EPS 0.040 ZacksConsensus 0.070 ActVsEst (0.030) - Miss
-13.9%
5/8 Form 4 ORASURE TECHNOLOGIES For: May 07 Filed by: Cuca Roberto -12.9%
3/14 OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.7%
3/17 OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -9.5%
3/20 OraSure up 8% premarket on potential use of collection devices for Covid-19 [Seeking Alpha] -8.8%
4/27 The 'breakthrough' a top White House official says we need [CNN] -7.2%
8/14 OraSure Technologies, Inc. (NASDAQ: OSUR) had its "hold" rating re-affirmed by analysts at Canaccord Genuity. They now have a $7.00 price target on the stock. -5.0%
11/8 Form 10-Q ORASURE TECHNOLOGIES For: Sep 30 -3.4%
12/3 OraSure Technologies, Inc. (NASDAQ: OSUR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -3.4%
10/19 OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -3.3%
5/8 Form 4 ORASURE TECHNOLOGIES For: May 07 Filed by: Cuca Roberto -12.9%
3/14 OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -9.7%
3/17 OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -9.5%
3/20 OraSure up 8% premarket on potential use of collection devices for Covid-19 [Seeking Alpha] -8.8%
4/27 The 'breakthrough' a top White House official says we need [CNN] -7.2%
8/14 OraSure Technologies, Inc. (NASDAQ: OSUR) had its "hold" rating re-affirmed by analysts at Canaccord Genuity. They now have a $7.00 price target on the stock. -5.0%
11/8 Form 10-Q ORASURE TECHNOLOGIES For: Sep 30 -3.4%
12/3 OraSure Technologies, Inc. (NASDAQ: OSUR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -3.4%
10/19 OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -3.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: